CHEK2 and breast cancer: Another recent large study by Stolarova et al. [22], functionally characterized 427 CHEK2 VUS selected by the international ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) consortium for variants with an association to an increased risk of breast cancer.